Orlen S.A. elected Ireneusz Fafara as its new CEO after dismissing Daniel Obajtek from the post in early February. Fafara was appointed to the management board's joint term of office, which ends on the date that the Ordinary General Meeting approves the company's financial statements for 2025. The appointment is effective April 11.

Fafara is an expert with knowledge of the fuel sector and the challenges related to energy transformation. In the years 2010-2018, he was the president of Orlen Lietuva, the company's Lithuanian subsidiary operating the only petroleum refinery in the Baltic states. Since June 2020, he has been the president of 4Cell Therapies, a company in the medical sector.

Obajtek, the CEO of Orlen of six years, was dismissed by the group's supervisory board on February 1, effective February 5. For many in the new government Obajtek was seen as being too close to the old Law and Justice government, which lost power in October's general election. He was also dogged by controversies surrounding his assets and the sale by Orlen of a stake in the Lotos refinery to a Saudi Arabian company.